Trexquant Investment’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Trexquant Investment’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73,900	Closed	-$1.1M	–	1895
2022 Q4	$1.1M	Buy	73,900 +47,130	+176%	+$653K	0.03%	611
2022 Q3	$220K	Buy	+26,770	New	+$206K	0.01%	1158
2021 Q1	–	Sell	-64,838	Closed	-$374K	–	1630
2020 Q4	$374K	Buy	64,838 +47,194	+267%	+$270K	0.04%	567
2020 Q3	$105K	Buy	+17,644	New	+$87.3K	0.01%	1140

Trexquant Investment's AVEO Position: Q1 2023 in Review

Trexquant Investment sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 73,900 shares — an estimated $1.1M sold.

Trexquant Investment first reported a position in AVEO in Q3 2020 and held it in 4 quarters. The position peaked at $1.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Trexquant Investment reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Trexquant Investment sold 73,900 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.1M.
Trexquant Investment first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2020 and held it in 4 quarters.
Trexquant Investment's AVEO Pharmaceuticals, Inc. position peaked at $1.1M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.